pI: 6.1468 |
Length (AA): 278 |
MW (Da): 30669 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
28 | 140 | 1z0n (A) | 77 | 163 | 33.00 | 0 | 1 | 0.6 | -0.65 |
28 | 120 | 1z0n (A) | 77 | 162 | 30.00 | 0 | 0.9 | 0.72 | -1.11 |
12 | 113 | 2lu3 (A) | 1 | 98 | 28.00 | 0 | 1 | 0.608006 | -0.13 |
22 | 88 | 2xu9 (A) | 65 | 124 | 40.00 | 0.66 | 0.19 | 0.368007 | 1.04 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127587)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G16360 | SNF1-related protein kinase regulatory subunit beta-2 |
Arabidopsis thaliana | AT2G28060 | 5'-AMP-activated protein kinase beta-2 subunit protein |
Babesia bovis | BBOV_IV004160 | hypothetical protein |
Brugia malayi | Bm1_05525 | 5'-AMP-activated protein kinase, beta subunit, complex-interacting region containing protein |
Brugia malayi | Bm1_18185 | 5'-AMP-activated protein kinase, beta subunit, complex-interacting region containing protein |
Candida albicans | CaO19.4084 | glucose repression |
Candida albicans | CaO19.11565 | glucose repression |
Caenorhabditis elegans | CELE_F55F3.1 | Protein AAKB-1 |
Caenorhabditis elegans | CELE_Y47D3A.15 | Protein AAKB-2 |
Cryptosporidium hominis | Chro.60240 | gal83 protein |
Cryptosporidium parvum | cgd6_2050 | AMP-activated protein kinase beta chain (has isoamylase N-terminal domain) |
Dictyostelium discoideum | DDB_G0281089 | AMP-activated protein kinase beta subunit |
Drosophila melanogaster | Dmel_CG8057 | alicorn |
Echinococcus granulosus | EgrG_000423400 | AMPK beta subunit |
Echinococcus multilocularis | EmuJ_000423400 | AMPK beta subunit |
Giardia lamblia | GL50803_101919 | 5-AMP-activated protein kinase, beta-1 subunit |
Homo sapiens | ENSG00000111725 | protein kinase, AMP-activated, beta 1 non-catalytic subunit |
Homo sapiens | ENSG00000131791 | protein kinase, AMP-activated, beta 2 non-catalytic subunit |
Leishmania braziliensis | LbrM.23.0520 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_230530.1 | 5'-AMP-activated protein kinase subunit beta, putative |
Leishmania infantum | LinJ.23.0530 | hypothetical protein, conserved |
Leishmania major | LmjF.23.0490 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.23.0490 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_06268 | 5'-AMP-activated protein kinase |
Mus musculus | ENSMUSG00000038205 | protein kinase, AMP-activated, beta 2 non-catalytic subunit |
Mus musculus | ENSMUSG00000029513 | protein kinase, AMP-activated, beta 1 non-catalytic subunit |
Neospora caninum | NCLIV_037390 | hypothetical protein |
Oryza sativa | 4344345 | Os07g0687300 |
Onchocerca volvulus | OVOC2137 | Alicorn homolog |
Saccharomyces cerevisiae | YGL208W | Sip2p |
Saccharomyces cerevisiae | YER027C | Gal83p |
Schistosoma japonicum | Sjp_0128580 | expressed protein |
Schistosoma mansoni | Smp_170160 | protein kinase subunit beta |
Schmidtea mediterranea | mk4.013965.02 | Alicorn |
Schmidtea mediterranea | mk4.010607.00 | |
Schmidtea mediterranea | mk4.013518.02 | |
Schmidtea mediterranea | mk4.026301.00 | |
Schmidtea mediterranea | mk4.023206.00 | |
Schmidtea mediterranea | mk4.037975.00 | |
Schmidtea mediterranea | mk4.015150.00 | |
Schmidtea mediterranea | mk4.016300.03 | Alicorn |
Schmidtea mediterranea | mk4.042077.00 | |
Trypanosoma brucei gambiense | Tbg972.8.1900 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.2450 | 5'-AMP-activated protein kinase subunit beta |
Trypanosoma cruzi | TcCLB.504427.50 | SNF1-related protein kinase regulatory subunit beta, putative |
Trypanosoma cruzi | TcCLB.509331.90 | 5'-AMP-activated protein kinase subunit beta, putative |
Toxoplasma gondii | TGME49_268960 | 5'-AMP-activated protein kinase subunit beta-1 family protein, putative |
Theileria parva | TP01_0339 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.2450 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2450 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2450 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.2450 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_268960 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | protein kinase, AMP-activated, beta 1 non-catalytic subunit | Compounds | References |
Homo sapiens | protein kinase, AMP-activated, beta 2 non-catalytic subunit | Compounds | References |